sycrest
n.v. organon - asenapine (as maleate) - bipolar disorder - psycholeptics - sycrest is indicated for the treatment of moderate to severe manic episodes associated with bipolar i disorder in adults.
sycrest 10mg sublingual tablets
lundbeck ltd - asenapine maleate - sublingual tablet - 10mg
sycrest 5mg sublingual tablets
lundbeck ltd - asenapine maleate - sublingual tablet - 5mg
saphris 5 mg
merck sharp & dohme (israel - 1996) company ltd, israel - asenapine as maleate - tablets sublingual - asenapine as maleate 5 mg - asenapine - asenapine - schizophrenia saphris is indicated for the treatment of schizophrenia in adults. the efficacy of saphris was established in two 6-week trials and one maintenance trial in adults bipolar disorder monotherapy: saphris is indicated for the acute treatment of manic or mixed episodes associated with bipolar i disorder. efficacy was established in two 3-week monotherapy trials in adults adjunctive therapy: saphris is indicated as adjunctive therapy with either lithium or valproate for the acute treatment of manic or mixed episodes associated with bipolar i disorder. efficacy was established in one 3-week adjunctive trial in adults.
saphris 10 mg
merck sharp & dohme (israel - 1996) company ltd, israel - asenapine as maleate - tablets sublingual - asenapine as maleate 10 mg - asenapine - asenapine - schizophrenia saphris is indicated for the treatment of schizophrenia in adults. the efficacy of saphris was established in two 6-week trials and one maintenance trial in adults bipolar disorder monotherapy: saphris is indicated for the acute treatment of manic or mixed episodes associated with bipolar i disorder. efficacy was established in two 3-week monotherapy trials in adults adjunctive therapy: saphris is indicated as adjunctive therapy with either lithium or valproate for the acute treatment of manic or mixed episodes associated with bipolar i disorder. efficacy was established in one 3-week adjunctive trial in adults.
saphris sublingual tablet 10mg
msd pharma (singapore) pte. ltd. - asenapine maleate 14.06mg eqv asenapine - tablet, orally disintegrating - 10mg
saphris sublingual tablet 5mg
msd pharma (singapore) pte. ltd. - asenapine maleate 7.03mg eqv asenapine - tablet, orally disintegrating - 5mg
saphris tablet
organon canada inc. - asenapine (asenapine maleate) - tablet - 5mg - asenapine (asenapine maleate) 5mg - atypical antipsychotics
saphris tablet
organon canada inc. - asenapine (asenapine maleate) - tablet - 10mg - asenapine (asenapine maleate) 10mg - atypical antipsychotics
mint-olanzapine odt tablet (orally disintegrating)
mint pharmaceuticals inc - olanzapine - tablet (orally disintegrating) - 5mg - olanzapine 5mg - atypical antipsychotics